London, United Kingdom · Founded 2019 · Privately Held (backing)
Operator of a biotechnology platform intended to restore vision for people with degenerative ocular diseases. Tenpoint Therapeutics is based in London, United Kingdom and was founded in 2019. Its last reported valuation was $76.6 million in Jul 2023. It has raised $312 million.
Last reported valuation
$76.6M
Oct 2026
Priced at
—
Total raised
$312.1M
Last round
—
Team — not yet on record
No current team members for Tenpoint Therapeutics are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Tenpoint Therapeutics with a free account
·The complete investor list: 15 names
·Watch Tenpoint Therapeutics: the Monday email on marks, rounds and moves
